Description
This completely updated 2nd edition to Kalorama’s popular 2003 study focuses on the market applications of current and advanced drug delivery technology to the development of new and modified pharmaceutical products in the United States. Taking a strategic view of the various therapeutic areas on which drug delivery is anticipated to have its greatest impact, the report considers the options that the current technologies present, the progress that is being made in these fields, and the reception these new products are likely to experience in the marketplace.
In particular, the 400-page study examines the market potential of modified-delivery therapeutics in the following therapeutic categories:
- Cardiovascular Diseases (including Coronary Stents),
- Cancer,
- Central Nervous System (CNS) Applications,
- Diabetes,
- Fertility Control and Women’s Health,
- Infectious Diseases, and
- Pulmonary Diseases (including upper respiratory conditions)
This report discusses the economic aspects of certain advanced drug delivery technologies and applications, and their impacts on formularies, insurers and patients. In addition to the market analysis and a thorough review of available technologies and those in development, the report extensively profiles the leading delivery technology companies, noting their portfolios, development pipelines, financial performance, and strategic partnerships.
Market analysis for this report considers the markets modified drug delivery products only in the United States. The focus of the report is on the application of advanced drug delivery technology in the improvements of existing pharmaceuticals and the facilitation of the delivery and commercialization of new therapeutics emerging from the biotechnology and biopharmaceutical industries.
The analysis presented in this report is based on data from a combination of company, government, industrial, institutional and private sources. It includes information from extensive literature reviews, as well as interviews and discussions with experts in the field, including experts in drug delivery technology, as well as medicinal chemists, research scientists, and business development and marketing managers engaged in the field.
